Exponent, Inc. (NASDAQ:EXPO)‘s stock had its “hold” rating restated by research analysts at SunTrust Banks, Inc. in a report released on Thursday, October 19th. They presently have a $77.00 price objective on the business services provider’s stock. SunTrust Banks, Inc.’s target price would indicate a potential upside of 3.08% from the stock’s previous close. SunTrust Banks also issued estimates for Exponent’s Q4 2017 earnings at $0.41 EPS, FY2017 earnings at $2.08 EPS, Q1 2018 earnings at $0.48 EPS, Q2 2018 earnings at $0.54 EPS, Q3 2018 earnings at $0.47 EPS, Q4 2018 earnings at $0.46 EPS and FY2018 earnings at $1.95 EPS.
EXPO has been the subject of several other research reports. Cantor Fitzgerald boosted their price target on shares of Exponent to $82.00 and gave the stock an “overweight” rating in a research note on Thursday, October 19th. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. Zacks Investment Research cut shares of Exponent from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Finally, BidaskClub upgraded shares of Exponent from a “strong sell” rating to a “sell” rating in a research report on Wednesday, July 5th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $80.00.
Shares of Exponent (EXPO) traded up 1.77% during midday trading on Thursday, reaching $74.70. The company had a trading volume of 98,282 shares. The company has a 50-day moving average price of $73.27 and a 200 day moving average price of $64.75. Exponent has a one year low of $55.75 and a one year high of $77.15. The company has a market capitalization of $1.93 billion, a P/E ratio of 38.72 and a beta of 0.61.
Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Wednesday, October 18th. The business services provider reported $0.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.45 by $0.09. The firm had revenue of $87.60 million for the quarter, compared to analyst estimates of $79.69 million. Exponent had a net margin of 16.46% and a return on equity of 17.21%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.42 EPS. Equities analysts anticipate that Exponent will post $2.09 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/29/exponents-expo-hold-rating-reaffirmed-at-suntrust-banks-inc.html.
In other Exponent news, CEO Paul R. Johnston sold 3,000 shares of the firm’s stock in a transaction on Friday, September 29th. The shares were sold at an average price of $74.01, for a total transaction of $222,030.00. Following the completion of the transaction, the chief executive officer now directly owns 32,342 shares of the company’s stock, valued at approximately $2,393,631.42. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Paul R. Johnston sold 5,000 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $64.41, for a total transaction of $322,050.00. Following the transaction, the chief executive officer now directly owns 66,335 shares of the company’s stock, valued at $4,272,637.35. The disclosure for this sale can be found here. In the last three months, insiders sold 75,993 shares of company stock worth $5,109,149. Insiders own 2.80% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of EXPO. UBS Asset Management Americas Inc. boosted its holdings in shares of Exponent by 37.2% in the 1st quarter. UBS Asset Management Americas Inc. now owns 56,173 shares of the business services provider’s stock valued at $3,345,000 after buying an additional 15,221 shares during the period. Karp Capital Management Corp acquired a new position in shares of Exponent in the 1st quarter valued at about $549,000. Parametric Portfolio Associates LLC boosted its holdings in shares of Exponent by 11.9% in the 1st quarter. Parametric Portfolio Associates LLC now owns 79,840 shares of the business services provider’s stock valued at $4,754,000 after buying an additional 8,502 shares during the period. Ameritas Investment Partners Inc. bought a new stake in Exponent in the 1st quarter valued at about $132,000. Finally, Victory Capital Management Inc. lifted its position in Exponent by 9.2% in the 1st quarter. Victory Capital Management Inc. now owns 2,683 shares of the business services provider’s stock valued at $160,000 after purchasing an additional 226 shares during the last quarter. 88.23% of the stock is owned by institutional investors and hedge funds.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Exponent Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.